Core Viewpoint - Hengxin Life has shown a mixed performance in terms of financing activities and stockholder dynamics, with a notable increase in revenue and net profit year-on-year, indicating potential growth in the biodegradable and non-biodegradable product markets [1][2]. Financing Activities - On January 19, Hengxin Life's stock price increased by 0.55%, with a trading volume of 40.91 million yuan. The financing buy-in amount was 2.08 million yuan, while the financing repayment was 3.06 million yuan, resulting in a net financing outflow of 0.98 million yuan [1]. - As of January 19, the total balance of margin trading for Hengxin Life was 106 million yuan, with a financing balance of 105 million yuan, accounting for 6.49% of the circulating market value [1]. - The company had no shares repaid in the securities lending market on January 19, with 300 shares sold short, amounting to 13,200 yuan at the closing price, and a remaining short balance of 6,900 shares valued at 303,200 yuan [1]. Company Performance - As of January 9, Hengxin Life had 12,000 shareholders, a decrease of 2.27% from the previous period, with an average of 3,076 circulating shares per person, an increase of 2.32% [2]. - For the period from January to September 2025, Hengxin Life achieved an operating income of 1.384 billion yuan, representing a year-on-year growth of 19.49%, and a net profit attributable to shareholders of 185 million yuan, reflecting a year-on-year increase of 14.12% [2]. - Since its A-share listing, Hengxin Life has distributed a total of 51 million yuan in dividends [2]. Shareholder Dynamics - As of September 30, 2025, Hong Kong Central Clearing Limited was the fifth-largest circulating shareholder of Hengxin Life, holding 259,500 shares, which is a decrease of 922,800 shares compared to the previous period [2].
恒鑫生活1月19日获融资买入208.04万元，融资余额1.05亿元